Back to Search
CASSANDRA LILLI, DO
DO
Psychiatry Physician
NPI: 1770111437IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
2024-00609(NC)
CMS Specialties
PrimaryPSYCHIATRY
Education
WEST VIRGINIA SCHOOL OF OSTEOPATHIC MEDICINE
Class of 2020
Research & Publications (20)
FGF2 effects in periosteal fibroblasts bearing the FGFR2 receptor Pro253 Arg mutation.
PMID 17537644·Cytokine·2007
8-other
Effects of transforming growth factor-beta1 and tumour necrosis factor-alpha on cultured fibroblasts from skin fibroma as modulated by toremifene.
PMID 11948458·Int J Cancer·2002
4-observational
Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
PMID 18155395·Biomed Pharmacother·2008
8-other
Comparative in vitro studies on the fibrogenic effects of two samples of silica on epithelial bronchial cells.
PMID 18261261·J Biol Regul Homeost Agents·2007
4-observational
Unique human CD133+ leukemia cell line and its modulation towards a mesenchymal phenotype by FGF2 and TGFbeta1.
PMID 16222707·J Cell Physiol·2006
7-preclinical
In vitro human osteoblast and extracellular matrix changes after transforming growth factor beta 1 treatment.
PMID 16194844·Pathology·2005
8-other
Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene.
PMID 15740610·BMC Cancer·2005
8-other
P253R fibroblast growth factor receptor-2 mutation induces RUNX2 transcript variants and calvarial osteoblast differentiation.
PMID 15389579·J Cell Physiol·2005
8-other
Bronchial branching correlates with specific glycosidase activity, extracellular glycosaminoglycan accumulation, TGF beta(2), and IL-1 localization during chick embryo lung development.
PMID 14966199·J Histochem Cytochem·2004
7-preclinical
Silica, hyaluronate, and alveolar macrophage functional differentiation.
PMID 12643514·J Investig Med·2003
7-preclinical
Cross-talk between interleukin-6 and transforming growth factor-beta3 regulates extracellular matrix production by human fibroblasts from subjects with non-syndromic cleft lip and palate.
PMID 14653390·J Periodontol·2003
8-other
Biocompatibility of collagen membranes crosslinked with glutaraldehyde or diphenylphosphoryl azide: an in vitro study.
PMID 14566791·J Biomed Mater Res A·2003
8-other
Basic fibroblast growth factor autocrine loop controls human osteosarcoma phenotyping and differentiation.
PMID 12393937·Mol Med·2002
4-observational
Biomembranes enriched with TGFbeta1 favor bone matrix protein expression by human osteoblasts in vitro.
PMID 12209903·J Biomed Mater Res·2002
8-other
Crouzon's syndrome: differential in vitro secretion of bFGF, TGFbeta I isoforms and extracellular matrix macromolecules in patients with FGFR2 gene mutation.
PMID 12182844·Cytokine·2002
8-other
Basic fibroblast growth factor: effects on matrix remodeling, receptor expression, and transduction pathway in human periosteal fibroblasts with FGFR2 gene mutation.
PMID 12162872·J Interferon Cytokine Res·2002
4-observational
Synthesis and secretion of transforming growth factor-beta1 by human desmoid fibroblast cell line and its modulation by toremifene.
PMID 11747628·J Interferon Cytokine Res·2001
4-observational
Bronchial epithelial cell matrix production in response to silica and basic fibroblast growth factor.
PMID 11471549·Mol Med·2001
8-other
In vitro comparison of bioabsorbable and non-resorbable membranes in bone regeneration.
PMID 11453237·J Periodontol·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1120 FAIRGROVE CHURCH RD STE 12
HICKORY, NC 28602 - Phone
- (828) 326-2828
Quick Facts
- NPI
- 1770111437
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile